Published Technical Disclosure Archive

Smart Supraglottic Airway Device System

Publication ID: 24-11857709_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Smart Supraglottic Airway Device System,” Published Technical Disclosure No. 24-11857709_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857709_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,709.

Summary of the Inventive Concept

A novel system integrating a supraglottic airway device with AI, IoT, blockchain, and advanced materials to minimize contamination exposure, optimize performance, and ensure sterility tracking.

Background and Problem Solved

The original supraglottic airway device patent addressed the need for a medical airway device that reduces potential contamination exposure to patients and medical professionals. However, it lacked real-time monitoring and control capabilities, AI-driven optimization, IoT connectivity, and advanced materials for enhanced performance and sterility. The new inventive concept solves these limitations by introducing a synergistic combination of these technologies.

Detailed Description of the Inventive Concept

The Smart Supraglottic Airway Device System comprises a sensor-integrated coupler device that detects contamination exposure and transmits real-time data to a remote monitoring station via a wireless communication module. An AI-powered algorithm analyzes the data and adjusts the suction operation to minimize contamination exposure. The system also features IoT connectivity, enabling real-time data transmission to a cloud-based server and mobile application notifications. Additionally, the device incorporates a self-cleaning surface coating and biocompatible material to reduce bacterial adhesion and patient discomfort. A blockchain-based system tracks and verifies the device's sterility, ensuring a secure and transparent record of usage and sterilization history.

Novelty and Inventive Step

The new claims introduce a novel combination of AI, IoT, blockchain, and advanced materials that significantly enhances the original supraglottic airway device's functionality and performance. The integration of these technologies provides a non-obvious solution to the problem of contamination exposure and sterility tracking in medical airway devices.

Alternative Embodiments and Variations

Alternative embodiments of the Smart Supraglottic Airway Device System could include varying sensor types, AI algorithm modifications, and different IoT connectivity protocols. Variations may also include the use of other advanced materials, such as antimicrobial coatings or nanomaterials, to further enhance the device's performance and sterility.

Potential Commercial Applications and Market

The Smart Supraglottic Airway Device System has significant commercial potential in the medical device industry, particularly in the fields of anesthesiology, critical care, and emergency medicine. The system's ability to minimize contamination exposure, optimize performance, and ensure sterility tracking addresses a critical need in the market, providing a competitive advantage for manufacturers and healthcare providers.

CPC Classifications

SectionClassGroup
A A61 A61M16/0409
A A61 A61M16/0445
A A61 A61M16/0463
A A61 A61M16/0816
A A61 A61M16/0833
A A61 A61M16/0858
A A61 A61M16/105
A A61 A61M39/06
A A61 A61M16/0434
A A61 A61M16/0683
A A61 A61M16/1055
A A61 A61M2205/583

Field of Art

Medical Device Engineering, specifically Supraglottic Airway Device Technologies, involving respiratory medical equipment design, sensor integration, and advanced materials for patient care devices

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in respiratory medical technologies, familiar with sensor integration, wireless communication protocols, and advanced materials science, holding at least a master's degree or equivalent professional experience

Obviousness Rationale

A PHOSITA would recognize that integrating digital monitoring, AI analysis, and advanced materials into existing supraglottic airway device architectures represents a predictable technological evolution driven by emerging healthcare digitization trends. The source patent's foundational design provides a clear framework for incorporating sensor and communication technologies to enhance device functionality. The proposed variations represent incremental improvements using well-established engineering techniques and commercially available technologies.

Obvious Combinations & Variations

Source Patent Element
Coupler assembly with pressure port and filter configuration
PTD Variation
Adding sensor integration and wireless communication module to coupler device
Obviousness Reasoning
Adding electronic sensors to medical devices is a known technique for performance monitoring, with predictable results in enhancing device functionality and patient safety
Source Patent Element
Inflatable cuff and pilot balloon system
PTD Variation
Implementing AI-powered algorithm to dynamically adjust device performance based on sensor data
Obviousness Reasoning
Adaptive control systems for medical devices are well-established, and applying machine learning to existing mechanical systems represents a standard engineering approach
Source Patent Element
Contaminant-blocking air pass filter
PTD Variation
Incorporating self-cleaning surface coating and advanced biocompatible materials
Obviousness Reasoning
Material science innovations for reducing bacterial adhesion are a predictable extension of existing contamination prevention strategies in medical device design
Source Patent Element
Breathing tube with outer and inner wall configuration
PTD Variation
Adding IoT connectivity and blockchain-based tracking for device sterility management
Obviousness Reasoning
Digital tracking and verification systems are standard approaches for enhancing medical device traceability and quality control
Source Patent Element
Basic supraglottic airway device structure
PTD Variation
Creating a comprehensive system with remote monitoring, AI analysis, and real-time performance tracking
Obviousness Reasoning
Integrating digital technologies into medical devices represents a natural technological progression with predictable improvements in monitoring and patient care
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857709 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed Smart Supraglottic Airway Device System claims obvious and anticipated, as the combination of known techniques, predictable sensor integration, and standard digital monitoring approaches do not represent a non-obvious technological advancement beyond the existing prior art.

Original Patent Information

Patent NumberUS 11,857,709
TitleSupraglottic airway device